-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
CytomX Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2019 to 2024.
- CytomX Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 84.7M shares, a 14.8% increase year-over-year.
- CytomX Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 84.7M shares, a 14.8% increase from 2023.
- CytomX Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 73.8M shares, a 12.3% increase from 2022.
- CytomX Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 65.7M shares, a 2.48% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)